Terms: = Kidney tumors AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
53 results:
1. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
2. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
[TBL] [Abstract] [Full Text] [Related]
3. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract] [Full Text] [Related]
4. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
[TBL] [Abstract] [Full Text] [Related]
6. Golgi Phosphoprotein 3 Promotes Malignant Phenotypes via FAK/Raf/MEK and Wnt/
He M; Wang Z; Hu W; Wang K; Wang D; Fang Z; Huang A; Gao Y; Xia J; Li W
J Biomed Nanotechnol; 2019 Aug; 15(8):1812-1823. PubMed ID: 31219012
[TBL] [Abstract] [Full Text] [Related]
7. Renal Cell Carcinoma With Extensive Tumor Thrombus Into the Inferior Vena Cava and Right Atrium in a 70-Year-Old Man.
Oltean MA; Matuz R; Sitar-Taut A; Mihailov A; Rednic N; Tantau A; Toganel R; Minciuna IA; Orasan O; Muresan F; Cozma A
Am J Mens Health; 2019; 13(3):1557988319846404. PubMed ID: 31046582
[TBL] [Abstract] [Full Text] [Related]
8. Association of Target Therapy Gene Expression with Metastasizing of Clear-Cell Renal Cell Carcinoma.
Apanovich NV; Peters MV; Apanovich PV; Markova AS; Kamolov BS; Matveev VB; Karpukhin AV
Bull Exp Biol Med; 2018 Dec; 166(2):257-259. PubMed ID: 30488209
[TBL] [Abstract] [Full Text] [Related]
9. DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor.
Kanno E; Kawasaki O; Takahashi K; Takano K; Endo T
Exp Cell Res; 2018 Jan; 362(1):111-120. PubMed ID: 29129563
[TBL] [Abstract] [Full Text] [Related]
10. Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms.
Queisser N; Schupp N; Schwarz E; Hartmann C; Mackenzie GG; Oteiza PI
Mol Carcinog; 2017 Aug; 56(8):1868-1883. PubMed ID: 28272757
[TBL] [Abstract] [Full Text] [Related]
11. [Activation of AKT of signaling pathway and the level of mTOR substrates in tumor of patients with kidney cancer, connection with prevalence of malignancy].
Spirina LV; Usynin EA; Kondakova IV; Yurmazov ZA; Slonimskaya EM; Kolegova ES
Vopr Onkol; 2016; 62(3):490-4. PubMed ID: 30463106
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Labenski M; Mastrandrea NJ; Canatsey RD; Monks TJ; Lau SS
Mol Carcinog; 2016 Aug; 55(8):1243-50. PubMed ID: 26333016
[TBL] [Abstract] [Full Text] [Related]
13. Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial c-raf-DAPK Complex by Raf Inhibitor Combination Therapy.
Tsai YT; Chuang MJ; Tang SH; Wu ST; Chen YC; Sun GH; Hsiao PW; Huang SM; Lee HJ; Yu CP; Ho JY; Lin HK; Chen MR; Lin CC; Chang SY; Lin VC; Yu DS; Cha TL
Cancer Res; 2015 Sep; 75(17):3568-82. PubMed ID: 26100670
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population.
Cao Q; Wang J; Zhang M; Li P; Qian J; Zhang S; Zhang L; Ju X; Wang M; Zhang Z; Li J; Gu M; Zhang W; Qin C; Shao P; Yin C
PLoS One; 2014; 9(10):e109285. PubMed ID: 25329396
[TBL] [Abstract] [Full Text] [Related]
15. Indole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells.
Wang YQ; Chen C; Chen Z; Xu Y; Wang Y; Xiao BK; Chen SM; Tao ZZ
Oncol Rep; 2013 Jul; 30(1):227-33. PubMed ID: 23604413
[TBL] [Abstract] [Full Text] [Related]
16. Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.
Zhu Y; Xu L; Zhang J; Hu X; Liu Y; Yin H; Lv T; Zhang H; Liu L; An H; Liu H; Xu J; Lin Z
Cancer Sci; 2013 Aug; 104(8):1052-61. PubMed ID: 23578198
[TBL] [Abstract] [Full Text] [Related]
17. Reduced expression of raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
Moon A; Park JY; Sung JY; Park YK; Kim YW
Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
[TBL] [Abstract] [Full Text] [Related]
18. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
[TBL] [Abstract] [Full Text] [Related]
19. ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Gard JM; Nagle RB; Dietrich JD; Monks TJ; Lau SS
Toxicol Sci; 2011 Nov; 124(1):75-87. PubMed ID: 21813464
[TBL] [Abstract] [Full Text] [Related]
20. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract] [Full Text] [Related]
[Next]
